|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||
|
||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sF0B2FCFE-3AE4-11EF-B77C-C0D584CE164B&I=39IZM&T=&OP=Display&O=html&O1=12856241&O2=4100000007108706&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DBenefit-risk%2520assessment%2520of%2520BCG%2520vaccine%2520in%2520Russia%253A%2520%25E2%2580%259CPrinciple%2520of%2520three%25E2%2580%259D%2520method%26rft.au%3DB.%2520K.%2520Romanov%26rft.au%3DI.%2520I.%2520Snegiryova%26rft.au%3DK.%2520E.%2520Zatolochina%26rft.date%3D2022-06-01%26rft.eissn%3D2619-1164%26rft.epage%3D21%26rft.externalDBID%3DDOA%26rft.externalDocID%3Doai_doaj_org_article_8fb803521fab453db80eb251bc477505%26rft.genre%3Darticle%26rft.issn%3D2312-7821%26rft.issue%3D2%26rft.jtitle%3DBezopasnost%25CA%25B9%2520i%2520risk%2520farmakoterapii%2520%2528Online%2529%26rft.pub%3DMinistry%2520of%2520Health%2520of%2520the%2520Russian%2520Federation%252C%2520Federal%2520State%2520Budgetary%2520Institution%2520%25C2%25ABScientific%2520Centre%2520for%2520Expert%2520Evaluation%2520of%2520Medicinal%2520Products%26rft.spage%3D17%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-REFWORKS_EXPORT_TOOL-getReference-object,4-GOOGLE_SCHOLAR_FREE-getWebSearch-object,5-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.389298&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12856241-sF0B2FCFE-3AE4-11EF-B77C-C0D584CE164B" timestamp="2024-07-05T17:40:44Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4100000007108706</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Benefit-risk assessment of BCG vaccine in Russia: “Principle of three” method</jnl:atitle>
<jnl:jtitle>Безопасность и риск фармакотерапии</jnl:jtitle>
<jnl:date>2022-06-01</jnl:date>
<jnl:spage>17</jnl:spage>
<jnl:epage>21</jnl:epage>
<jnl:issn>2312-7821</jnl:issn>
<jnl:issue>2</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2619-1164</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:4987a4c8aa8094d6f730a655d9f583f3dd4de4d7</ctx:identifier>
<ctx:identifier>urn:UUID:sF0B2FCFE-3AE4-11EF-B77C-C0D584CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)